Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed +113.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$3.3M→$447,0003 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CSPI financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed across a sign change
Operating cash flow changed +113.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$3.3M→$447,0003 prior comparisons
Stock-based compensation increased 32.0%
Stock-based compensation changed +32.0% from the comparable as-filed period.
$403,000→$532,0003 prior comparisons
Working capital / assets moved 1048 bp lower
Working capital / assets changed -1048 basis points from the comparable as-filed period.
51.12%→40.64%3 prior comparisons
Gross margin moved 127 bp higher
Gross margin changed +127 basis points from the comparable as-filed period.
28.83%→30.09%3 prior comparisons
Receivables / revenue moved 821 bp lower
Receivables / revenue changed -821 basis points from the comparable as-filed period.
87.09%→78.87%0 prior comparisons
Capital expenditure decreased 100.0%
Capital expenditure changed -100.0% from the comparable as-filed period.
$66,000→$03 prior comparisons
Free-cash-flow margin moved 2478 bp higher
Free-cash-flow margin changed +2478 basis points from the comparable as-filed period.
-21.68%→3.10%3 prior comparisons
Operating cash-flow margin moved 2436 bp higher
Operating cash-flow margin changed +2436 basis points from the comparable as-filed period.
-21.25%→3.10%3 prior comparisons
Capex / revenue moved 43 bp lower
Capex / revenue changed -43 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
0.43%→0.00%3 prior comparisons
Revenue decreased 6.8%
Revenue changed -6.8% from the comparable as-filed period.
$15.4M→$14.4M3 prior comparisons
Trade receivables decreased 15.6%
Trade receivables changed -15.6% from the comparable as-filed period.
$13.5M→$11.4M1 prior comparisons
SBC / revenue moved 109 bp higher
SBC / revenue changed +109 basis points from the comparable as-filed period.
2.61%→3.69%3 prior comparisons
Cash & equivalents decreased 6.2%
Cash & equivalents changed -6.2% from the comparable as-filed period.
$26.3M→$24.7M3 prior comparisons
Total assets increased 6.0%
Total assets changed +6.0% from the comparable as-filed period.
$66.8M→$70.8M3 prior comparisons
Shares outstanding increased 2.2%
Shares outstanding changed +2.2% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
9,861,327→10,080,6458 prior comparisons
Cost of revenue decreased 8.5%
Cost of revenue changed -8.5% from the comparable as-filed period.
$11.0M→$10.1M3 prior comparisons
Selling, general & administrative increased 3.2%
Selling, general & administrative changed +3.2% from the comparable as-filed period.
$4.9M→$5.0M3 prior comparisons
Research & development increased 5.2%
Research & development changed +5.2% from the comparable as-filed period.
$791,000→$832,0003 prior comparisons
R&D / revenue moved 66 bp higher
R&D / revenue changed +66 basis points from the comparable as-filed period.
5.12%→5.78%3 prior comparisons
Current assets decreased 0.5%
Current assets changed -0.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$49.5M→$49.2M4 prior comparisons
Gross profit decreased 2.7%
Gross profit changed -2.7% from the comparable as-filed period.
$4.5M→$4.3M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.